Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Arm Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology in Subjects With Chronic Kidney Disease Receiving Dialysis
Conditions
Interventions
Epoetin alfa DT
Start Date
April 1, 2005
Primary Completion Date
February 1, 2007
Completion Date
February 1, 2007
Last Updated
February 19, 2010
NCT07241390
NCT06926660
NCT06717698
NCT07450820
NCT06306963
NCT04592640
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions